Fmoc-L-His(3-Me)-OH

Fmoc-L-His(3-Me)-OH is an Fmoc-protected L-histidine derivative bearing a 3-methyl substituent on the imidazole ring, placing it in the protected amino acid class used for peptide assembly. The molecule contains a free carboxylic acid and an Fmoc carbamate on the α-amino group, while the side-chain imidazole is substituted to modulate its hydrogen-bonding and acid-base behavior relative to unmodified histidine. In synthesis, it functions as a stepwise incorporation building block for solid-phase peptide synthesis and related peptide chemistry workflows, where the Fmoc group supports controlled amide-bond formation and the substituted imidazole provides a defined functional side chain for structure-activity and chemical biology studies.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.

CAT No: CP25665

CAS No:252049-16-4

Synonyms/Alias:252049-16-4;Fmoc-His(pi-Me)-OH;Fmoc-His(3-Me)-OH;SCHEMBL15729186;MolPort-023-223-417;ZINC2392285;6899AH

Chemical Name:N-alpha-(9-Fluorenylmethyloxycarbonyl)-N3-methyl-L-histidine

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
M.F/Formula
C22H21N3O4
M.W/Mr.
391,42 g/mole

Fmoc-L-His(3-Me)-OH is an Fmoc-protected L-histidine derivative bearing a 3-methyl substituent on the imidazole ring, creating a chiral amino acid building block with an N-(9H-fluoren-9-ylmethoxycarbonyl) protected α-amino group and a free carboxylic acid for peptide coupling. The imidazole side chain is substituted at the 3-position, which modulates basicity, metal-binding behavior, and hydrogen-bonding patterns relative to canonical histidine while retaining the heteroaromatic functionality needed for coordination and recognition chemistry. The combination of an Fmoc carbamate and a stereodefined L-configuration supports standard orthogonal protection strategies in solid-phase or solution-phase peptide synthesis. The resulting protected amino acid intermediate can be incorporated into peptides and peptidomimetics where histidine-like side-chain chemistry is tuned by methylation, enabling downstream functionalization and structure-controlled synthetic design.

1. Peptide Synthesis

Fmoc-L-His(3-Me)-OH supports peptide building block preparation for both solid-phase and solution-phase peptide synthesis, where the Fmoc group serves as a base-labile N-protecting group and the free carboxylic acid participates in amide bond formation. The L-histidine backbone provides a stereodefined α-center, while the 3-methyl imidazole maintains a heteroaromatic side chain suitable for coupling-compatible retention of side-chain functionality. The substituted imidazole can be used to control local polarity and metal-coordination propensity in peptide sequences without introducing additional protecting groups on the side chain. Incorporation into peptide chains enables construction of histidine analogs for peptide library generation, sequence optimization, and mechanistic studies of side-chain-dependent recognition.

2. Chemical Biology Probes

Fmoc-L-His(3-Me)-OH can be applied in chemical biology research to generate histidine-mimicking residues with altered protonation and coordination behavior for binding and labeling experiments. The 3-methyl substitution on the imidazole ring changes the electronic environment while preserving the heteroaromatic motif that can participate in hydrogen bonding and metal-ion interactions during biomolecular recognition. The Fmoc-protected α-amino group enables controlled incorporation into peptides, which can then serve as scaffolds for ligand presentation, receptor-binding probes, or enzyme-interaction studies. Downstream derivatization of the peptide product can leverage the tuned imidazole chemistry to influence assay readouts in biochemical research workflows.

3. Peptidomimetics And SAR

Fmoc-L-His(3-Me)-OH is suitable for peptidomimetic construction and structure-activity relationship studies where histidine side-chain tuning is required to probe functional contributions of imidazole chemistry. The chiral amino acid framework and protected amine allow systematic placement of a 3-methyl imidazole residue into peptide analogs, enabling side-chain modification without changing the backbone stereochemistry. The substituted imidazole can modulate binding modes through altered basicity and steric/electronic effects, supporting SAR designs that distinguish effects of histidine N3 substitution versus native histidine. Peptide analogs prepared from this building block can be used as research intermediates for fragment-based scaffold refinement and for generating structure-defined series of analogs in medicinal chemistry.

4. Metal Binding Materials

Fmoc-L-His(3-Me)-OH can be employed in functional material synthesis and specialty chemical production where imidazole-containing polymers or crosslinkers require controlled metal coordination sites. The amino acid derivative provides a defined stereocenter and an Fmoc-protected handle that can be incorporated into peptide-like segments or polymerizable units, while the 3-methyl imidazole offers a coordination motif with modified donor properties. The carboxylic acid functionality enables conversion into activated derivatives for coupling into larger macromolecular architectures, supporting reproducible placement of metal-binding groups. Resulting imidazole-rich materials can serve as processable ligating components for coordination-driven assembly, surface binding, or ion-interaction studies in applied chemical development.

5. Process Chemistry Intermediate

Fmoc-L-His(3-Me)-OH functions as a chiral amino acid intermediate for process chemistry routes that require reliable orthogonal protection behavior and predictable peptide-coupling compatibility. The Fmoc carbamate provides a standardized N-protection strategy that can be removed under controlled conditions during manufacturing of protected peptides, while the free carboxyl group supports formation of amide linkages using common coupling chemistries. The 3-methyl imidazole side chain remains chemically present through peptide assembly, reducing the need for additional side-chain protection and supporting streamlined intermediate handling. Downstream, the prepared peptide or peptidomimetic intermediates can be further transformed into conjugates, analytical standards, or specialized fine chemicals, aligning with industrial workflows for amino acid derivative synthesis.

Size
1 g;5 g;
InChI
1S/C22H21N3O4/c1-25-13-23-11-14(25)10-20(21(26)27)24-22(28)29-12-19-17-8-4-2-6-15(17)16-7-3-5-9-18(16)19/h2-9,11,13,19-20H,10,12H2,1H3,(H,24,28)(H,26,27)/t20-/m0/s1
InChI Key
UEDYXEZHNPXCFB-FQEVSTJZSA-N
Canonical SMILES
CN1C=NC=C1CC(C(=O)O)NC(=O)OCC2C3=CC=CC=C3C4=CC=CC=C24

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
cGMP Peptide ServicePeptide Analysis ServicesPeptide Modification ServicesEpitope Mapping ServicesPeptide Synthesis ServicesPeptide CDMOPeptide Nucleic Acids SynthesisCustom Conjugation Service
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers